This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
| Yesterday’s UK 100 Leaders | Price (p) | % Chg |
| Croda International PLC | 2,701.0 | 5.7% |
| Polar Capital Technology Trust PLC | 435.5 | 3.4% |
| Halma PLC | 3,382.0 | 3.4% |
| ICG PLC | 2,332.0 | 3.1% |
| Coca-Cola Europacific Partners PLC | 6,620.0 | 3.0% |
| Yesterday’s UK 100 Laggards | Price (p) | % Chg |
| Endeavour Mining PLC | 2,692.0 | -3.9% |
| Next PLC | 11,575.0 | -3.3% |
| WPP PLC | 380.4 | -2.4% |
| Vodafone Group PLC | 84.6 | -1.7% |
| Rio Tinto PLC | 4,572.0 | -1.7% |
| Major World Indices | Price | % Chg | 1 Year |
| UK 100 INDEX | 9,228 | 0.2% | 10.8% |
| DOW JONES INDUS. AVG | 46,142 | 0.3% | 9.8% |
| DAX INDEX | 23,675 | 1.4% | 24.6% |
| NIKKEI 225 | 45,034 | 0.6% | 21.0% |
| S&P/ASX 200 INDEX | 8,774 | 0.3% | 7.4% |
| Commodities | Units | Price | % Chg |
| WTI Crude Oil (Nymex) | USD/bbl. | 63.28 | -0.46% |
| Brent Crude (ICE) | USD/bbl. | 67.23 | -0.31% |
| Gold Spot | USD/t oz. | 3,653 | 0.2% |
| Copper (Comex) | USd/lb. | 461 | 0.2% |
Click graph to enlarge
The UK 100 is called to open +13 points this morning at 9,241. The UK 100 looks set to open marginally higher today. Having closed 0.2% or 19.74 points higher at 9,228.11 yesterday
Retail sales volumes grew by 0.5% in August, the Office for National Statistics reported today. The performance was in line with City expectations, following upwardly revised growth of 0.5% the previous month.Meanwhile, figures on the public finances showed the government borrowed a bigger-than-forecast £18 billion in August.
Stocks closed at record highs on Thursday Stateside, with smaller equities seeing the biggest boost, as the Federal Reserve signalled this week it was embarking on an easing rate path, reinvigorating investors and raising hopes for a ratcheting up of economic growth.
The S&P closed up 0.48% at 6,631.96, while the Nasdaq popped 0.94% to settle at 22,470.73. The Dow Jones added 124 points, or 0.27%, to close at 46,142.42. Each of the major U.S. indexes notched a fresh all-time intraday high on Thursday, just a day after stocks had a volatile trading session Wednesday in the wake of the Fed’s rate cut.
Spire Healthcare said on Thursday it had initiated discussions with several parties to explore strategic options, including a potential sale of the company. The company said the review was at an early stage, emphasizing that no decision had been made to pursue any specific option and that it had not received any approaches nor was it currently in discussions regarding a possible sale. Spire said it was working with lead financial adviser Rothschild & Co and would assess measures to enhance long-term shareholder value. The company noted that its property and asset base were not fully reflected in its market valuation. The company’s statement came after a Sky News report on Wednesday suggested some of Spire’s investors, including activist trust Achilles, part of Harwood Capital Management, had encouraged it to consider a sale. Spire, with a market valuation of 871.97 million pounds ($1.18 billion), according to LSEG data, operates 38 hospitals and more than 50 clinics, medical centers and consulting rooms across England, Wales and Scotland.
UK
None
US
None
UK
None
US
None
UK GfK Consumer Confidence
German Producer Price Index
UK Retail Sales
ECB’s Sleijpen speech
UK 100 companies going ex-dividend on 25th September 2025:
Phoenix Group Holdings
Endeavour Mining
Rightmove
UK 250 companies going ex-dividend on 25th September 2025:
Pollen Street Group
Alfa Financial Software Holdings
Lion Finance Group
Drax Group
Computacenter
HgCapital Trust
JTC
Harworth Group
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.